| # | Drug | Count |
|---|---|---|
| 0 | FINASTERIDE | 1674 |
| 1 | LEVONORGESTREL | 761 |
| 2 | PAROXETINE HYDROCHLORIDE | 406 |
| 3 | TADALAFIL | 384 |
| 4 | ESCITALOPRAM | 340 |
| 5 | VENLAFAXINE HYDROCHLORIDE | 328 |
| 6 | CITALOPRAM | 322 |
| 7 | SERTRALINE | 313 |
| 8 | BUPROPION HYDROCHLORIDE | 309 |
| 9 | FLUOXETINE HYDROCHLORIDE | 291 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PYCNOGENOL 6X | 3 | 0.0349 |
| 1 | FINASTERIDE | 1674 | 0.0274 |
| 2 | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | 3 | 0.0270 |
| 3 | TRIFLUOPERAZINE HYDROCHLORIDE | 3 | 0.0238 |
| 4 | L-TYROSINE | 3 | 0.0221 |
| 5 | BREMELANOTIDE | 18 | 0.0157 |
| 6 | DROSPIRENONE AND ESTETROL | 4 | 0.0135 |
| 7 | DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE | 13 | 0.0124 |
| 8 | VORTIOXETINE | 203 | 0.0118 |
| 9 | TESTOSTERONE GEL, 1% | 3 | 0.0118 |
| # | Drug class | Count |
|---|---|---|
| 0 | 5-alpha Reductase Inhibitor [EPC] | 1809 |
| 1 | Progestin [EPC] | 965 |
| 2 | Progestin-containing Intrauterine System [EPC] | 764 |
| 3 | Benzodiazepine [EPC] | 735 |
| 4 | Atypical Antipsychotic [EPC] | 651 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 634 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 402 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 296 |
| 8 | Corticosteroid [EPC] | 285 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 271 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 5-alpha Reductase Inhibitor [EPC] | 1809 | 0.0177 |
| 1 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 266 | 0.0103 |
| 2 | Provitamin D2 Compound [EPC] | 271 | 0.0091 |
| 3 | Androgen [EPC] | 113 | 0.0041 |
| 4 | Adrenocorticotropic Hormone [EPC] | 3 | 0.0034 |
| 5 | Progestin [EPC] | 965 | 0.0033 |
| 6 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 4 | 0.0031 |
| 7 | Opioid Antagonist [EPC] | 3 | 0.0031 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 402 | 0.0030 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |